+++ Das Finanz-Event für Privatanleger & Trader: 35 Expertenvorträge beim Börsentag Wien am 8. März 2025 - jetzt kostenfrei anmelden! +++ -w-
11.08.2022 16:00:06

Abbott: Research Shows TBI Blood Test Helpful In Predicting Recovery From Traumatic Brain Injury

(RTTNews) - Abbott (ABT) said a new study concluded that elevated levels of two proteins help predict how a person will recover from a traumatic brain injury. The research showed that when a clinician conducts a blood test for these brain proteins soon after a possible injury, they quickly get a more accurate picture of how severe the injury is, the expected course of recovery and the longer-term implications. The researchers used Abbott's i-STAT TBI Plasma test and core laboratory ARCHITECT instrument to measure two biomarkers in blood plasma associated with brain injury.

Abbott is pursuing FDA clearance under Breakthrough Designation for the TBI test on its Alinity i and ARCHITECT core laboratory instruments. Abbott's TBI test on Alinity i is CE Marked and available outside the U.S.

For More Such Health News, visit rttnews.com.

Analysen zu Abbott Laboratoriesmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Abbott Laboratories 129,56 0,11% Abbott Laboratories